Bridgepoint Group plc (LON:BPT - Get Free Report) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 310 ($4.08) and last traded at GBX 310 ($4.08), with a volume of 27519 shares. The stock had previously closed at GBX 302.60 ($3.98).
Wall Street Analysts Forecast Growth
A number of analysts have commented on the stock. JPMorgan Chase & Co. raised shares of Bridgepoint Group to an "overweight" rating and upped their price objective for the company from GBX 259 ($3.41) to GBX 358 ($4.71) in a research note on Tuesday, August 13th. Jefferies Financial Group restated a "buy" rating and issued a GBX 310 ($4.08) price target on shares of Bridgepoint Group in a research report on Tuesday, July 9th.
View Our Latest Stock Analysis on Bridgepoint Group
Bridgepoint Group Stock Performance
The stock has a market capitalization of £2.36 billion, a PE ratio of 3,730.00, a P/E/G ratio of 0.61 and a beta of 1.72. The company has a debt-to-equity ratio of 14.55, a quick ratio of 3.60 and a current ratio of 4.98. The firm has a 50 day moving average of GBX 267.68 and a 200-day moving average of GBX 252.35.
Bridgepoint Group Increases Dividend
The firm also recently announced a dividend, which will be paid on Monday, October 28th. Stockholders of record on Thursday, September 19th will be issued a GBX 4.60 ($0.06) dividend. This is an increase from Bridgepoint Group's previous dividend of $4.40. The ex-dividend date is Thursday, September 19th. This represents a dividend yield of 1.67%. Bridgepoint Group's dividend payout ratio is currently 11,250.00%.
About Bridgepoint Group
(
Get Free Report)
Bridgepoint Group plc is private equity and private credit firm specializing in middle market, lower mid cap, small cap, growth capital and buyouts investment. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
Featured Stories
Before you consider Bridgepoint Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bridgepoint Group wasn't on the list.
While Bridgepoint Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
